A detailed history of Tortoise Investment Management, LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Tortoise Investment Management, LLC holds 263 shares of CRL stock, worth $42,874. This represents 0.01% of its overall portfolio holdings.

Number of Shares
263
Previous 148 77.7%
Holding current value
$42,874
Previous $29,000 65.52%
% of portfolio
0.01%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 07, 2025

BUY
$178.58 - $220.69 $20,536 - $25,379
115 Added 77.7%
263 $48,000
Q3 2024

Nov 13, 2024

BUY
$187.96 - $245.29 $3,195 - $4,169
17 Added 12.98%
148 $29,000
Q2 2024

Aug 01, 2024

BUY
$206.39 - $268.73 $11,764 - $15,317
57 Added 77.03%
131 $27,000
Q1 2024

May 09, 2024

BUY
$203.52 - $273.43 $15,060 - $20,233
74 New
74 $20,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.29B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Tortoise Investment Management, LLC Portfolio

Follow Tortoise Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tortoise Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tortoise Investment Management, LLC with notifications on news.